INIT.ST Stock Analysis
IN
Uncovered
Initiator Pharma A/S is uncovered by Eyestock quantitative analysis.
Market cap $B
0.038
Dividend yield
—
Shares outstanding
52.282 B
Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. The firm focuses on developing drugs for treatment of erectile dysfunction.
View Section: Eyestock Rating